Fassnacht M[Author] - Search Results

Year	Number of Results
1996	1
1998	1
2000	3
2001	7
2002	3
2003	5
2004	5
2005	7
2006	9
2007	4
2008	7
2009	15
2010	18
2011	22
2012	20
2013	20
2014	21
2015	30
2016	23
2017	20
2018	28
2019	30
2020	29
2021	10

1

Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.

Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, Tabarin A, Terzolo M, Tsagarakis S, Dekkers OM. Fassnacht M, et al. Eur J Endocrinol. 2016 Aug;175(2):G1-G34. doi: 10.1530/EJE-16-0467. Eur J Endocrinol. 2016. PMID: 27390021 Free article.

2

A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.

Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, Christ E, Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, Brabant G, Fassnacht M, Christ-Crain M. Fenske W, et al. Among authors: fassnacht m. N Engl J Med. 2018 Aug 2;379(5):428-439. doi: 10.1056/NEJMoa1803760. N Engl J Med. 2018. PMID: 30067922 Free article.

3

European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.

Fassnacht M, Dekkers OM, Else T, Baudin E, Berruti A, de Krijger R, Haak HR, Mihai R, Assie G, Terzolo M. Fassnacht M, et al. Eur J Endocrinol. 2018 Oct 1;179(4):G1-G46. doi: 10.1530/EJE-18-0608. Eur J Endocrinol. 2018. PMID: 30299884

4

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.

Zheng S, Cherniack AD, Dewal N, Moffitt RA, Danilova L, Murray BA, Lerario AM, Else T, Knijnenburg TA, Ciriello G, Kim S, Assie G, Morozova O, Akbani R, Shih J, Hoadley KA, Choueiri TK, Waldmann J, Mete O, Robertson AG, Wu HT, Raphael BJ, Shao L, Meyerson M, Demeure MJ, Beuschlein F, Gill AJ, Sidhu SB, Almeida MQ, Fragoso MCBV, Cope LM, Kebebew E, Habra MA, Whitsett TG, Bussey KJ, Rainey WE, Asa SL, Bertherat J, Fassnacht M, Wheeler DA; Cancer Genome Atlas Research Network, Hammer GD, Giordano TJ, Verhaak RGW. Zheng S, et al. Among authors: fassnacht m. Cancer Cell. 2016 May 9;29(5):723-736. doi: 10.1016/j.ccell.2016.04.002. Cancer Cell. 2016. PMID: 27165744 Free PMC article.

5

Combination chemotherapy in advanced adrenocortical carcinoma.

Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; FIRM-ACT Study Group. Fassnacht M, et al. N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May 2. N Engl J Med. 2012. PMID: 22551107 Free article. Clinical Trial.

6

Next-generation therapies for adrenocortical carcinoma.

Altieri B, Ronchi CL, Kroiss M, Fassnacht M. Altieri B, et al. Among authors: fassnacht m. Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101434. doi: 10.1016/j.beem.2020.101434. Epub 2020 Jun 18. Best Pract Res Clin Endocrinol Metab. 2020. PMID: 32622829 Review.

7

Advanced Adrenocortical Carcinoma - What to do when First-Line Therapy Fails?

Megerle F, Kroiss M, Hahner S, Fassnacht M. Megerle F, et al. Among authors: fassnacht m. Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):109-116. doi: 10.1055/a-0715-1946. Epub 2018 Nov 23. Exp Clin Endocrinol Diabetes. 2019. PMID: 30469158 Free article. Review.

8

European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.

Plouin PF, Amar L, Dekkers OM, Fassnacht M, Gimenez-Roqueplo AP, Lenders JW, Lussey-Lepoutre C, Steichen O; Guideline Working Group. Plouin PF, et al. Among authors: fassnacht m. Eur J Endocrinol. 2016 May;174(5):G1-G10. doi: 10.1530/EJE-16-0033. Eur J Endocrinol. 2016. PMID: 27048283 Review.

9

Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis.

Belavgeni A, Bornstein SR, von Mässenhausen A, Tonnus W, Stumpf J, Meyer C, Othmar E, Latk M, Kanczkowski W, Kroiss M, Hantel C, Hugo C, Fassnacht M, Ziegler CG, Schally AV, Krone NP, Linkermann A. Belavgeni A, et al. Among authors: fassnacht m. Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22269-22274. doi: 10.1073/pnas.1912700116. Epub 2019 Oct 14. Proc Natl Acad Sci U S A. 2019. PMID: 31611400 Free PMC article.

10

Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma.

Assié G, Jouinot A, Fassnacht M, Libé R, Garinet S, Jacob L, Hamzaoui N, Neou M, Sakat J, de La Villéon B, Perlemoine K, Ragazzon B, Sibony M, Tissier F, Gaujoux S, Dousset B, Sbiera S, Ronchi CL, Kroiss M, Korpershoek E, De Krijger R, Waldmann J, Quinkler M, Haissaguerre M, Tabarin A, Chabre O, Luconi M, Mannelli M, Groussin L, Bertagna X, Baudin E, Amar L, Coste J, Beuschlein F, Bertherat J. Assié G, et al. Among authors: fassnacht m. JAMA Oncol. 2019 Jul 11;5(10). doi: 10.1001/jamaoncol.2019.1558. Online ahead of print. JAMA Oncol. 2019. PMID: 31294750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results